Harvard 5th Annual Update Neuro-Oncology 2025 (Videos with subtitles + Slides)

5th Annual Update in Neuro-Oncology
Deepen your expertise in neuro-oncology with this expert-led course offering the latest advances in diagnosis, treatment, and management of CNS and PNS tumors and neurological complications of cancer

Overview

Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). The field of neuro-oncology also encompasses neurogenetic syndromes, like neurofibromatosis, associated with nervous system tumors and various neurological complications of cancer and cancer treatments. In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification.
This three-day CME course, the 5th Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors, specific neurogenetic syndromes, and neurological complications of cancer.
The target audience consists of providers and trainees involved in the care of adult and pediatric neuro-oncology patients (neurologists, oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, nurses, and industry professionals.
Learning Objectives

Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and manage neurological complications associated with new cancer therapies.
Describe and manage long-term complications of CNS and PNS tumors and their treatment.

Schedule
Day 1 – Wednesday, July 23, 2025
Theme: Pediatric Neuro-Oncology

Opening Remarks: Pediatric Neuro-Oncology Session
Speaker: Lissa BairdTime: 10:00 – 10:10 am

Session I: Pediatric CNS Tumors

Time
Session Title
Speaker(s)

10:10 – 10:40 am
WHO Classification, Pediatric CNS Tumors
Sanda Alexandrescu

10:40 – 11:10 am
Advances in the Imaging of Pediatric Brain Tumors
Tina Young Poussaint

11:10 – 11:30 am
Embryonal Tumors
Susan Chi

11:30 – 11:50 am
Pediatric Low-Grade Gliomas
Pratiti Bandopadhayay

Break
Time: 11:50 am – 12:00 pm

Session II: Pediatric Brain Tumors

Time
Session Title
Speaker(s)

12:00 – 12:30 pm
Pediatric High-Grade Gliomas
Mariella Filbin

12:30 – 12:45 pm
Ependymomas
Karen Wright

12:45 – 1:15 pm
Live Q&A Session
Lissa Baird

Break
Time: 1:15 – 1:30 pm

Session III: Pediatric Tumors

Time
Session Title
Speaker(s)

1:30 – 1:45 pm
Choroid Plexus Tumors
Viviana Benitez

1:45 – 2:00 pm
Pineal Tumors
Shannon MacDonald

2:00 – 2:15 pm
Germ Cell Tumors
Kee Kiat Yeo

2:15 – 2:45 pm
Neurofibromatosis and Schwannomatosis
Justin Jordan

2:45 – 3:00 pm
Von Hippel Lindau
Othon Iliopoulos

3:00 – 3:15 pm
Live Q&A Session
Lissa Baird

Live CNS Tumor Board
Speakers: Mariella Filbin, Ralph SalloumTime: 3:15 – 3:45 pm

Adjourn
Time: 3:45 – 3:50 pm

Day 2 – Thursday, July 24, 2025
Theme: Adult Neuro-Oncology

Welcome: Adult Neuro-Oncology
Speaker: Tracy BatchelorTime: 10:00 – 10:05 am

Session IV: Brain Tumor Surgery & Imaging

Time
Session Title
Speaker(s)

10:05 – 10:20 am
Advances in Surgery for Brain Tumors
E. Antonio Chiocca

10:20 – 10:35 am
Advances in the Imaging of Adult Brain Tumors
Raymond Huang

10:35 – 10:50 am
Advances in Radiation for Brain Tumors
Ariel Marciscano

10:50 – 11:20 am
WHO Classification for Adult Gliomas
Maria Martinez-Lage Alvarez

Live Q&A Session
Speaker: Tracy BatchelorTime: 11:20 – 11:35 am

Break
Time: 11:35 am – 12:00 pm

Session V: Adult Gliomas

Time
Session Title
Speaker(s)

12:00 – 12:30 pm
Gliomas, IDH-Mutant
L. Nicolas Gonzalez Castro

12:30 – 12:45 pm
Gliomas, IDH-Wildtype
Isabel Arrillaga-Romany

12:45 – 1:15 pm
Advances in Experimental Therapies for Gliomas
David Reardon

Live CNS Tumor Board
Speaker: L. Nicolas Gonzalez CastroTime: 1:15 – 1:45 pm

Break
Time: 1:45 – 2:00 pm

Session VI: Meningiomas & CNS Lymphomas

Time
Session Title
Speaker(s)

2:00 – 2:15 pm
Meningiomas
Wenya Linda Bi

2:15 – 2:30 pm
CNS Lymphomas
Tracy Batchelor

2:30 – 2:45 pm
Pituitary Tumors
Pamela Jones

2:45 – 3:00 pm
Live Q&A Session
L. Nicolas Gonzalez Castro

Adjourn
Time: 3:00 – 3:05 pm

Day 3 – Friday, July 25, 2025
Theme: Neurological Complications of Cancer

Welcome: Neurological Complications of Cancer
Speaker: Patrick WenTime: 10:00 – 10:05 am

Session VII: Cancer Metastases

Time
Session Title
Speaker(s)

10:05 – 10:35 am
Metastases to the Brain
Priscilla Brastianos

10:35 – 10:50 am
Metastases to the Leptomeninges
Nancy Wang

10:50 – 11:05 am
Metastases to the Epidural Space and Spinal Cord
John Chi

11:05 – 11:20 am
Paraneoplastic Neurological Syndromes
David Gritsch

Live Q&A Session
Speaker: Patrick WenTime: 11:20 – 11:40 am

Break
Time: 11:40 am – 12:00 pm

Session VIII: Neurological Complications in Cancer

Time
Session Title
Speaker(s)

12:00 – 12:30 pm
Common Neurological Complications in Cancer Patients
Julie Miller

12:30 – 12:45 pm
Neurological Complications of Cancer Immunotherapies
Jorg Dietrich

12:45 – 1:00 pm
Survivorship of CNS Tumors
Deborah Forst

Live Q&A Session
Speaker: Patrick WenTime: 1:00 – 1:15 pm

Live CNS Tumor Board
Speaker: Annie HsiehTime: 1:15 – 1:45 pm

Closing Statements
Speaker: Tracy BatchelorTime: 1:45 – 2:00 pm